Screening of antigenic vesicular fluid proteins of Echinococcus multilocularis as potential viability biomarkers to monitor drug response in alveolar echinococcosis patients.

Valot, Benoît; Rognon, Bénédicte; Prenel, Anais; Baraquin, Alice; Knapp, Jenny; Anelli, Mathilde; Richou, Carine; Bresson-Hadni, Solange; Grenouillet, Frederic; Wang, Junhua; Vuitton, Dominique Angèle; Gottstein, Bruno; Millon, Laurence (2017). Screening of antigenic vesicular fluid proteins of Echinococcus multilocularis as potential viability biomarkers to monitor drug response in alveolar echinococcosis patients. Proteomics. Clinical applications, 11(11-12) Wiley 10.1002/prca.201700010

Text Valot_et_al-2017-PROTEOMICS_-_Clinical_Applications.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (875kB)

PURPOSE

The only drugs available to treat alveolar echinococcosis (AE) are mostly parasitostatic and in many cases prescribed for life. Decision criteria for discontinuation rely on the absence of parasitic viability. The aim of the present study is to search for candidate proteins that may exhibit good potential as biomarkers for viability.

EXPERIMENTAL DESIGN

Sixteen serum samples (five healthy controls, 11 patients with AE), are used. AE-patients are classified into three groups "Cured" (n = 2), "ABZ-responders" (n = 4) and "ABZ-nonresponders" (n = 5). Immunoreactive proteins from vesicular fluid (VF) are identified and quantified by LC-MS/MS analysis after immunoprecipitation (IP) using all 16 serum samples.

RESULTS

Shotgun analysis of VF lead to the identification of 107 E. multilocularis proteins. Comparative proteomics reveal nine proteins more abundant in IP eluates from ABZ-nonresponder patients (cathepsin b, prosaposin a preprotein, actin modulator protein, fucosidase alpha L1 tissue, gluthatione-S-tranferase, beta galactosidase, elongation factor 2, H17g protein tegumental antigen, and NiemannPick C2 protein).

CONCLUSIONS AND CLINICAL RELEVANCE

Detection of antibodies against these proteins by ELISA could be helpful to monitor the course of alveolar echinococcosis under albendazole (ABZ) treatment.

Interest & Impact

Downloads

0 since deposited on 17 May 2018
0 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item